In summary, CSCs release a variety of immunosuppressive cytokines and chemotactic factors such as; PGE2, IL-10, TGF-β, IL-4, IL-13 and IL-35 that affect different immune cells in the TME and promote tumor invasion and progression. The gene discussed is IL13; the disease is neoplasm.